85 related articles for article (PubMed ID: 18483251)
1. Targeted knockout of BRG1 potentiates lung cancer development.
Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D
Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251
[TBL] [Abstract][Full Text] [Related]
2. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.
Orvis T; Hepperla A; Walter V; Song S; Simon J; Parker J; Wilkerson MD; Desai N; Major MB; Hayes DN; Davis IJ; Weissman B
Cancer Res; 2014 Nov; 74(22):6486-6498. PubMed ID: 25115300
[TBL] [Abstract][Full Text] [Related]
3. Loss of the SWI/SNF ATPase subunits BRM and BRG1 drives lung cancer development.
Marquez-Vilendrer SB; Rai SK; Gramling SJ; Lu L; Reisman DN
Oncoscience; 2016; 3(11-12):322-336. PubMed ID: 28105457
[TBL] [Abstract][Full Text] [Related]
4. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.
Tagal V; Wei S; Zhang W; Brekken RA; Posner BA; Peyton M; Girard L; Hwang T; Wheeler DA; Minna JD; White MA; Gazdar AF; Roth MG
Nat Commun; 2017 Jan; 8():14098. PubMed ID: 28102363
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.
Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T
Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725
[TBL] [Abstract][Full Text] [Related]
6. Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells.
Wu Q; Sharma S; Cui H; LeBlanc SE; Zhang H; Muthuswami R; Nickerson JA; Imbalzano AN
Oncotarget; 2016 May; 7(19):27158-75. PubMed ID: 27029062
[TBL] [Abstract][Full Text] [Related]
7. Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics.
Kadoch C; Crabtree GR
Sci Adv; 2015 Jun; 1(5):e1500447. PubMed ID: 26601204
[TBL] [Abstract][Full Text] [Related]
8. The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
Vangamudi B; Paul TA; Shah PK; Kost-Alimova M; Nottebaum L; Shi X; Zhan Y; Leo E; Mahadeshwar HS; Protopopov A; Futreal A; Tieu TN; Peoples M; Heffernan TP; Marszalek JR; Toniatti C; Petrocchi A; Verhelle D; Owen DR; Draetta G; Jones P; Palmer WS; Sharma S; Andersen JN
Cancer Res; 2015 Sep; 75(18):3865-3878. PubMed ID: 26139243
[TBL] [Abstract][Full Text] [Related]
9. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance.
Buscarlet M; Krasteva V; Ho L; Simon C; Hébert J; Wilhelm B; Crabtree GR; Sauvageau G; Thibault P; Lessard JA
Blood; 2014 Mar; 123(11):1720-8. PubMed ID: 24478402
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
Kadoch C; Hargreaves DC; Hodges C; Elias L; Ho L; Ranish J; Crabtree GR
Nat Genet; 2013 Jun; 45(6):592-601. PubMed ID: 23644491
[TBL] [Abstract][Full Text] [Related]
11. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters.
Tolstorukov MY; Sansam CG; Lu P; Koellhoffer EC; Helming KC; Alver BH; Tillman EJ; Evans JA; Wilson BG; Park PJ; Roberts CW
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10165-70. PubMed ID: 23723349
[TBL] [Abstract][Full Text] [Related]
12. Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors.
Rodriguez-Nieto S; Cañada A; Pros E; Pinto AI; Torres-Lanzas J; Lopez-Rios F; Sanchez-Verde L; Pisano DG; Sanchez-Cespedes M
Hum Mutat; 2011 Feb; 32(2):E1999-2017. PubMed ID: 21280140
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
Wilson BG; Wang X; Shen X; McKenna ES; Lemieux ME; Cho YJ; Koellhoffer EC; Pomeroy SL; Orkin SH; Roberts CW
Cancer Cell; 2010 Oct; 18(4):316-28. PubMed ID: 20951942
[TBL] [Abstract][Full Text] [Related]
14. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
Rodriguez-Nieto S; Sanchez-Cespedes M
Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
[TBL] [Abstract][Full Text] [Related]
15. The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
Navickas SM; Giles KA; Brettingham-Moore KH; Taberlay PC
Oncogene; 2023 Jul; 42(31):2363-2373. PubMed ID: 37433987
[TBL] [Abstract][Full Text] [Related]
16. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription.
Khavari PA; Peterson CL; Tamkun JW; Mendel DB; Crabtree GR
Nature; 1993 Nov; 366(6451):170-4. PubMed ID: 8232556
[TBL] [Abstract][Full Text] [Related]
17. Acute depletion of BRG1 reveals its primary function as an activator of transcription.
Ren G; Ku WL; Ge G; Hoffman JA; Kang JY; Tang Q; Cui K; He Y; Guan Y; Gao B; Liu C; Archer TK; Zhao K
Nat Commun; 2024 May; 15(1):4561. PubMed ID: 38811575
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features.
Kawai H; Miura T; Kawamatsu N; Nakagawa T; Shiba-Ishii A; Yoshimoto T; Amano Y; Kihara A; Sakuma Y; Fujita K; Shibano T; Ishikawa S; Ushiku T; Fukayama M; Tsubochi H; Endo S; Hagiwara K; Matsubara D; Niki T
Virchows Arch; 2024 May; ():. PubMed ID: 38710944
[TBL] [Abstract][Full Text] [Related]
19. [SWI/SNF Complex Gene Mutations Promote the Liver Metastasis
of Non-small Cell Lung Cancer Cells in NSI Mice].
Gao L; Xie Z; Lin S; Lv Z; Zhou W; Chen J; Zhu L; Zhang L; Zeng P; Huang X; Yan W; Chen Y; Lu D; Zhang S; Guo W; Li P; Zhang X
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):753-764. PubMed ID: 37989338
[TBL] [Abstract][Full Text] [Related]
20. Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies.
Pan M; Jiang C; Zhang Z; Achacoso N; Solorzano-Pinto AV; Tse P; Chung E; Suga JM; Thomas S; Habel LA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
